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Abstract
Background: The widespread use of relative scales in socioepidemiological studies has recently
been criticized. The criticism is based mainly on the fact that the importance of different risk factors
in explaining social inequalities in cardiovascular disease (CVD) varies, depending on which scale is
used to measure social inequalities. The present study examines the importance of established risk
factors, as opposed to low-grade inflammation, in explaining socioeconomic differences in the
incidence of CVD, using both relative and absolute scales.
Methods: We obtained information on socioeconomic position (SEP), established risk factors
(smoking, hypertension, and hyperlipidemia), and low-grade inflammation as measured by high-
sensitive (hs) C-reactive protein (CRP) levels, in 4,268 Swedish men and women who participated
in the Malmö Diet and Cancer Study (MDCS). Data on first cardiovascular events, i.e., stroke or
coronary event (CE), was collected from regional and national registers. Social inequalities were
measured in relative terms, i.e., as ratios between incidence rates in groups with lower and higher
SEP, and also in absolute terms, i.e., as the absolute difference in incidence rates in groups with
lower and higher SEP.
Results: Those with low SEP had a higher risk of future CVD. Adjustment for risk factors resulted
in a rather small reduction in the relative socioeconomic gradient, namely 8% for CRP (≥ 3 mg/L)
and 21% for established risk factors taken together. However, there was a reduction of 18% in the
absolute socioeconomic gradient when looking at subjects with CRP-levels < 3 mg/L, and of 69%
when looking at a low-risk population with no smoking, hypertension, or hyperlipidemia.
Conclusion: C-reactive protein and established risk factors all contribute to socioeconomic
differences in CVD. However, conclusions on the importance of "modern" risk factors (here, CRP),
as opposed to established risk factors, in the association between SEP and CVD depend on the
scale on which social inequalities are measured. The one-sided use of the relative scale, without
including a background of absolute levels of disease, and of what causes disease, can consequently
prevent efforts to reduce established risk factors by giving priority to research and preventive
programs looking in new directions.
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Background
The associations between socioeconomic position (SEP)
and cardiovascular disease (CVD) are well documented
and relatively undisputed [1-3]. In the search for causal
explanations of socioeconomic differences in cardiovas-
cular diseases, it has been shown repeatedly that estab-
lished risk factors such as smoking, physical inactivity,
blood pressure, total-cholesterol, body mass index, and
blood glucose, account for less than 50% of the socioeco-
nomic differences in coronary heart disease (CHD) [4,5].
Much less is known about the reasons for the differences
in cerebrovascular disease [6]. Research into causal expla-
nations of socioeconomic differences in CVD has most
often used a relative scale, and it has been argued that rel-
ative measures are more appropriate for etiological inves-
tigations than absolute measures [7]. The increasing
awareness of the limitations of established risk factors in
explaining socioeconomic differences in CVD has stimu-
lated research in new directions and has revitalized old
ideas. One example of this is the increasing recognition of
an inflammatory component of atherogenesis [8,9],
where major acute-phase-proteins such as high sensitive
(hs) C-reactive protein (CRP) and fibrinogen have been
found to predict acute cardiovascular events [8]. Thus,
inflammation could in theory be another factor that
might explain the social gradient in CVD. However, the
notion that established risk factors have only modest
importance in explaining socioeconomic differences in
CVD, followed by a search for undiscovered risk factors,
has been criticized [10,11]. In a recent study by Lynch et
al. [11], it is well illustrated that the conclusions on the
importance of various risk factors heavily depend on the
scale on which social inequalities are measured. The
authors criticize the one-sided use of the relative scale over
the past two decades, and they want to make visible that
an absolute risk approach focuses attention on those risk
factors that cause most cases of disease. The consistent use
of the relative scale has important implications for the
choice of preventive strategies, in that the quest for new
factors may be at the expense of trying to reduce the levels
of established risk factors that explain most cases of CVD.
The aim of the present study was to replicate the analyses
by Lynch and co-authors [11] on the importance of vari-
ous risk factors in explaining socioeconomic differences
in CVD, this time in a Swedish context using similar meth-
odology. We wanted to examine the importance of estab-
lished risk factors, as opposed to low-grade inflammation
as measured by CRP levels, in explaining socioeconomic
differences in the incidence of CVD. However, instead of
restricting the analyses to coronary heart disease as in the
study by Lynch et al., we wanted to use a broader measure
of CVD, including both CE and stroke. In the analyses,
social inequalities were measured in relative terms, i.e. as
ratios between incidence rates in lower and higher SEP
groups, and also in absolute terms, i.e. the absolute differ-
ence in incidence rates in lower and higher SEP groups.
Methods
Study population
The subjects in this study constituted a sub-cohort of the
large, population-based Malmö Diet and Cancer Study
(MDCS) cohort [12,13]. A random fifty percent sample of
those born between 1926 and 1945 who entered the
MDCS between October 1991 and February 1994 (n =
12,445) were invited to take part in a study on the epide-
miology of carotid artery disease [14]. We included those
individuals who had accepted the invitation to join the
carotid artery disease study and who had completed a self-
administered questionnaire with questions on social and
psychosocial factors, which was completed as part of the
baseline examination (n = 4,884) [15]. Subjects were con-
sidered to have CVD if they had been treated for myocar-
dial infarction and/or stroke according to the national or
regional myocardial infarction register or stroke register.
Subjects with known CVD (87 men and 29 women) were
excluded from the analyses. Another 344 individuals were
excluded because of missing laboratory results, 150 indi-
viduals because of missing data on CRP, and 6 individuals
because of missing data on educational level. The remain-
ing 4,268 subjects, 2,501 women and 1,767 men aged
46–68 years, constituted the study population.
The study was approved by the Ethics Committee at Lund
University. All participants gave their informed consent.
Cardiovascular risk factors
Risk factors were estimated through laboratory tests,
examination at baseline and through the questionnaire
administered at the baseline visit. Details of assessment
procedures regarding smoking habits (never, former, and
current smoker), measurements of supine blood pressure
(mm Hg), low-density lipoprotein (LDL), high-density
lipoprotein (HDL), diabetes, use of blood pressure lower-
ing medication, and treatment for hyperlipidemia have
been reported previously [15]. Subjects were classified as
having hyperlipidemia if they used medication against
hyperlipidemia or if they had hypercholesterolemia (total
cholesterol ≥ 6.5 mmol/L) and/or hypertriglyceridemia
(defined as triglyceride levels > 2.3 mmol/L according to
the Swedish guidelines for treatment of hyperlipidemia)
[16]. Prevalent hypertension was defined as systolic blood
pressure of 160 mm Hg or more, a diastolic blood pres-
sure of 90 mm Hg or more, or self-reported use of antihy-
pertensive medication. Subjects were classified as having
diabetes mellitus if they reported the diagnosis in the
questionnaire, used anti-diabetic medication or had a
fasting whole venous blood glucose level of ≥ 6.1 mmol/
L. The analysis of CRP was done from frozen plasma sam-
ples gathered at the baseline examination using the Tina-BMC Public Health 2008, 8:189 http://www.biomedcentral.com/1471-2458/8/189
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quant® CRP latex high sensitivity assay (Roche Diagnos-
tics, Basel, Switzerland) on an ADVIA® 1650 Chemistry
System (Bayer Healthcare, NY, USA). Study samples were
analyzed as discrete samples and results were read in 6-
second intervals for a time period of one minute follow-
ing incubation for 5 minutes. The mean value of these
measurements was the result reported. The average coeffi-
cient of variation (CV) has in earlier studies on the MDCS
been documented as 4.59% [17].
Measurement of incident events
A cardiovascular event was defined as first CE or first
stroke, whichever came first.
For CE, each individual was followed until December 31,
2001, date of first CE, or death. Information on morbidity
and mortality in the MDCS was obtained by record link-
age with the National Inpatient Register (Swedish Board
on Health and Welfare), the Swedish Causes of Death
Register [18], and the Malmö Myocardial Infarction Regis-
ter [19]. Underlying causes of death and hospitalization
diagnosis, respectively, were coded in accordance with the
ninth version of the International Classification of Dis-
eases [20]. A coronary event was defined as fatal or non-
fatal myocardial infarction (code 410), or death caused by
ischemic heart disease (codes 412 and 414).
Record linkage with the Stroke Register of Malmö
(STROMA) gave information on morbidity and mortality
from stroke in the MDCS [21,22]. The National Inpatient
Register was used to retrieve information on cases who
had moved away from Malmö during follow-up. Informa-
tion on case retrieval, validity, and ascertainment of cases
in the MDCS has been described in detail previously [23].
Briefly, all cases were followed from baseline examina-
tion, until death, or December 31, 2001. Stroke was
defined as rapidly developing clinical signs of local or glo-
bal loss of cerebral functioning lasting > 24 h (or leading
to death before then). Classification as subarachnoid
hemorrhage (ICD-9 code 430) or intracerebral hemor-
rhage (ICD-9 code 431) required verification by com-
puted tomography (CT) and/or autopsy. Cerebral
infarction (ICD-9 code 434) was diagnosed when CT or
autopsy could verify the infarction and/or exclude hemor-
rhage and nonvascular disease. In subjects with more than
one stroke event, only the first event was used for the anal-
yses.
Measurement of educational level
Information on educational level was assessed using a
self-administered questionnaire. Educational level was
classified into three categories based on the length of edu-
cational achievement: (1) low educational level, i.e. 8
years of education or less, (2) intermediate educational
level, i.e. 9–12 years of education, and (3) high educa-
tional level, i.e. more than 12 years of education [15].
Statistical methods
Relative differences in mortality by educational level were
assessed by crude and also age-and sex-adjusted hazard
ratios (HR) in a Cox proportional hazards model. We cal-
culated absolute rate differences (ARD) in incidence of
CVD between educational groups (expressed as cases per
100,000 person-years at risk). Age- and sex-adjusted inci-
dence rates of first cardiovascular event according to edu-
cational level, were analyzed by a direct standardization
with equal weights. The analyses were performed: (a) on
the whole population, (b) on a low-risk population of
non-smokers without hypertension, and hyperlipidemia
and (c) on a population with CRP levels below 3 mg/L.
Furthermore, similar analyses were performed on a low-
risk population also excluding those with diabetes melli-
tus and on subjects with CRP levels below 1 mg/L.
Results
Baseline characteristics of the study population
Details of the study population are given in Table 1. Car-
diovascular event cases showed a pattern of risk factors
that was generally less favorable than that of non-cases.
For example, among the cases 33% had CRP levels exceed-
ing 3 mg/L, 40.1% were current smokers, 55.1% had
hyperlipidemia, 62.8% had hypertension and 12.5% had
diabetes. The corresponding percentages among the non-
cases were 22.4%, 22.1%, 46.4%, 39.3% and 4.6%,
respectively. Altogether, 92% of the cases had at least one
established risk factor (i.e. hypertension, hypercholestero-
lemia or smoking), 41% had two risk factors, and 9% had
all three risk factors. The corresponding proportions
among the non-cases were 70%, 29% and 3%. The cases
had a significantly higher proportion of subjects with low
educational attainment than the non-cases.
Educational level and first cardiovascular event in the 
whole population
As can be seen in Table 2, in the crude model, those with
low educational attainment had a more than three-times
higher hazard of incident CVD than those with high edu-
cational attainment. The corresponding hazard in those
with an intermediate level of education was twofold. The
absolute educational differences in incidence rates were
523 per 100,000 person-years when comparing the lowest
and the highest educational groups and 216 per 100,000
person-years when comparing the groups with intermedi-
ate and highest levels of education. Similar patterns of
associations were seen in the age- and sex-adjusted model,
although the relative and absolute socioeconomic differ-
ences were smaller than in the crude model.
CRP and first cardiovascular event in the whole population
CRP was associated with an increased risk of future cardi-
ovascular events even after adjustment for cardiovascular
risk factors, i.e. age, sex, current smoking, hypertension,
hyperlipidemia, diabetes, and BMI, where those with CRPBMC Public Health 2008, 8:189 http://www.biomedcentral.com/1471-2458/8/189
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levels above 3 mg/L had an HR of 1.6 (95% confidence
interval, CI: 1.1–2.4) compared to those with CRP levels
below 1 mg/L. Those with CRP levels between 1 and 3 mg/
L also showed an increased risk of a future cardiovascular
event, with an HR of 1.4 (95% CI: 1.0–2.1).
Educational level and first cardiovascular event in a 
population with CRP levels below 3 mg/L
In subjects with CRP levels below 3 mg/L, the group with
a low level of education had an HR of 3.2 (95% CI: 1.7–
6.2) and the group with an intermediate level of educa-
tion had an HR of 2.2 (95% CI: 1.1–4.2) compared to the
group with a high educational level (Table 3). This corre-
sponds to a reduction of approximately 8% and an
increase of approximately 20% in the relative inequalities
seen between the low and intermediate educational level
groups, respectively, and the high educational level group,
compared to when looking at the relative differences in
the whole population. The absolute educational differ-
ences were 429 per 100,000 person-years and 223 per
100,000 person-years for the groups with low and inter-
mediate educational levels, respectively, relative to the
group with high educational level. Similar patterns of
associations were seen in the age- and sex-adjusted model,
although with smaller relative and absolute socioeco-
nomic differences than for the crude model.
Table 1: Age-and sex-adjusted means and prevalences of educational level and cardiovascular risk factors by cardiovascular event 
status
Cardiovascular event‡ No cardiovascular event
(n = 196) (n = 4,072)
Age, years 60.5* 57.1
Male (%) 59.3* 39.9
Current smoking (%) 40.1* 22.1
Former smoking (%) 31.0 34.3
Hyperlipidemia (%)† 55.1* 46.4
Hypertension (%)† 62.8* 39.3
CRP above 3 mg/L (%) 33.0* 22.4
Diabetes mellitus (%) 12.5* 4.6
Educational level
8 years or less 59.8* 46.7
9 to 12 years 30.7 34.2
13 years or more 8.6* 18.9
* P-values are given for the difference in risk factor levels between those with and those without a cardiovascular event; *p < 0.05.
† Hyperlipidemia is defined as use of medication against hyperlipidemia, hypercholesterolemia (total-cholesterol > 6.5 mmol/L) and/or 
hypertriglyceridemia defined as triglycerides > 2.3 mmol/L; Hypertension was defined as systolic bloodpressure of 160 mm Hg or more, a diastolic 
bloodpressure of 90 mm Hg or more, or self-reported use of antihypertensive medication.
‡ A cardiovascular event was defined as first coronary event or first stroke, whichever came first.
Table 2: Relation between educational level and incident cases of first cardiovascular event (stroke or coronary event) in the whole 
population.
Crude model Age- and sex-adjusted model
Educational level N (%) No. of cases Incidence rate 
(per 100 000)
Hazard ratio 
(95% CI)†
Absolute 
difference
Incidence rate 
(per 100 000)
Hazard ratio 
(95% CI) †
Absolute 
difference
8 years of 
education or 
less
1,961 124 748 3.4 (2.0, 5.6) 523 683 2.8 (1.6, 4.7) 433
9 to 12 years of 
education
1,483 56 441 2.0 (1.1, 3.4) 216 456 1.9 (1.1, 3.4) 206
More than 12 
years of 
education*
824 16 225 1.0 0 250 1.0 0
Total 4,268 196 539 531
*Reference category
†CI; confidence intervalBMC Public Health 2008, 8:189 http://www.biomedcentral.com/1471-2458/8/189
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As seen in Figure 1, the difference in crude incidence rates
between the group with low educational level and the
group with high educational level was 523 per 100,000
person-years in the whole study population and 429 per
100,000 person-years in subjects with CRP levels below 3
mg/L. This gives a reduction in the excess risk between the
low and high educational level groups of 18%, i.e. (523-
429/523) * 100 compared to when looking at the whole
study population. The corresponding negative reduction
(i.e. increase) in excess risk between the groups with inter-
mediate and high educational levels was 3%, i.e. (216-
223/216) * 100. In the age- and sex-adjusted model (not
shown in the figure), the reduction in excess risk between
the groups with low and high educational level was 17%,
i.e. (433-358/433) * 100.
Educational level and first cardiovascular event in a 
population with CRP levels below 1 mg/L
In subjects with CRP levels below 1 mg/L (n = 1,797; cases
= 51), the group with low educational level had an HR of
4.2 (95% CI: 1.5–12.1) compared to the group with high
educational level (data not shown). This corresponds to
an approximately 33% increase in the relative inequalities
seen between the low educational level group and the
high educational level group compared to when using the
whole population. The crude incidence rates in the groups
with high, intermediate, and low educational levels were
115, 292, and 484 per 100,000 person-years, respectively.
The absolute educational differences were 369 and 177
per 100,000 person-years, for the low and intermediate
educational level groups, respectively, and the high educa-
tional level group. This gives a reduction in the excess risk
between the groups with low and high educational levels
of 29%, i.e. (523-369/523) * 100 compared to the whole
population. The corresponding reduction in excess risk
between the groups with intermediate and high educa-
tional levels was 18%, i.e. (216-177/216) * 100.
Educational level and first cardiovascular event in a low 
risk population
In a low-risk population (i.e. no hypertension, no hyper-
cholesterolemia, and no current smoking), the group with
Crude incidence rates of first cardiovascular event (i.e.  stroke or coronary event) by educational level in the whole  population (shown as dark grey and light grey bars) and in a  population with CRP below 3 mg/L (shown as light grey bars) Figure 1
Crude incidence rates of first cardiovascular event 
(i.e. stroke or coronary event) by educational level in 
the whole population (shown as dark grey and light 
grey bars) and in a population with CRP below 3 mg/
L (shown as light grey bars). ARD I stands for absolute 
difference in incidence rate between those with less than 9 
years of education and those with more than 12 years of 
education in the whole population. ARD II stands for the 
corresponding difference in a population with CRP-levels 
below 3 mg/L.
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Table 3: Relation between educational level and incident cases of first cardiovascular event (stroke or coronary event) in a population 
with CRP-levels below 3.
Crude model Age- and sex-adjusted model
Educational level N (%) No. of cases Incidence rate 
(per 100 000)
Hazard ratio 
(95% CI) †
Absolute 
difference
Incidence rate 
(per 100 000)
Hazard ratio 
(95% CI)†
Absolute 
Difference
8 years of 
education or 
less
1,443 76 619 3.2 (1.7, 6.2) 429 573 2.7 (1.4, 5.1) 358
9 to12 years of 
education
1,185 42 413 2.2 (1.1, 4.2) 223 443 2.2 (1.1, 4.3) 228
More than 12 
years of 
education*
668 11 190 1.0 0 215 1.0 0
Total 3,296 129 457 467
*Reference category
†CI; confidence intervalBMC Public Health 2008, 8:189 http://www.biomedcentral.com/1471-2458/8/189
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low educational level had an HR of 2.9 (95% CI: 0.6–
13.2) and the group with intermediate educational level
had an HR of 1.8 (95% CI: 0.4–8.9) compared to the high
educational level group (Table 4). This corresponds to
reductions of approximately 21% and 20% in the relative
inequalities seen between the low and intermediate edu-
cational level groups, respectively, and the high educa-
tional level group compared to when using the whole
study population. The absolute educational differences
were 163 per 100,000 person-years and 70 per 100,000
person-years, respectively, for the groups with low and
intermediate educational levels, respectively, compared to
the high educational level group. Similar patterns of asso-
ciations were seen in the age- and sex-adjusted model,
although with smaller relative and absolute socioeco-
nomic differences than for the crude model.
As seen in Figure 2, the difference in crude incidence rates
between the low educational level group and the high
educational level group was 523 per 100,000 person-years
in the whole study population and 163 per 100,000 per-
son-years in the low-risk population. This gives a reduc-
tion in the excess risk between the groups with low and
high educational levels of 69%, i.e. (523-163/523) * 100
compared to when looking at the whole study popula-
tion. The corresponding reduction in excess risk between
the groups with intermediate and high educational levels
was 67%, i.e. (216-70/216) * 100. In the age- and sex-
adjusted model (not shown in the figure), the reduction
in excess risk between the low and high educational level
groups was 78%, i.e. (433-93/433) * 100 and for the
intermediate educational level group it was 78%, i.e.
(206-46/206) * 100.
Educational level and first cardiovascular event in a low-
risk population, also adding absence of diabetes
If one also adds absence of diabetes when defining the
low-risk population (n = 1,064; cases = 15), the group
with a low educational level had an HR of 2.4 (95% CI:
0.4–9.1) and the group with an intermediate level of edu-
cation had an HR of 1.8 (95% CI: 0.5–10.9) compared to
the group with a high level of education (data not shown).
This corresponds to reductions of approximately 41% and
20% in the relative inequalities seen between the low and
intermediate educational level groups, respectively, and
the high educational level group compared to when using
the whole study population. The crude incidence rates in
the groups with high, intermediate, and low educational
levels were 90, 164, and 204 per 100,000 person-years,
respectively. The absolute educational differences were
114 per 100,000 person-years and 74 per 100,000 person-
years, between the low and intermediate educational level
groups, respectively, and the high educational level group.
This gives a reduction in the excess risk between the
groups with low and high educational levels of 78%, i.e.
(523-114/523) * 100 compared to when looking at the
whole study population. The corresponding reduction in
excess risk between the groups with intermediate and high
educational levels was 66%, i.e. (216-74/216) * 100.
Discussion
As has been shown in earlier studies [1-3,24], adjustment
for cardiovascular risk factors resulted in a rather small
reduction in the relative educational gradient in risk of
future CVD, i.e. 8% for CRP and 21% for established risk
factors taken together (current smoking, hypertension
and hyperlipidemia). When considering absolute educa-
Table 4: Relation between educational level and incident cases of first cardiovascular event (stroke or coronary event) in a low-risk 
population‡.
Crude model Age- and sex-adjusted model
Educational level N (%) No. of cases Incidence rate 
(per 100 000)
Hazard ratio 
(95% CI) †
Absolute 
difference
Incidence rate 
(per 100 000)
Hazard ratio 
(95% CI) †
Absolute 
difference
Less than 9 
years of 
education
408 9 253 2.9 (0.6, 13.2) 163 229 2.0 (0.4, 9.1) 93
9 to 12 years of 
education
428 6 160 1.8 (0.4, 8.9) 70 182 1.5 (0.3, 7.6) 46
More than 12 
years of 
education*
256 2 90 1.0 0 136 1.0 0
Total 1,092 17 151 193
*Reference category
†CI; confidence interval
‡Low risk population includes those with no current smoking, no hypertension (i.e., systolic blood pressure above 160 mm Hg and/or diastolic 
blood pressure above 90 mm Hg and/or treatment for hypertension), and no hyperlipidemia (i.e., total-cholesterol > = 6.5 mmol/L and/or 
triglycerides > 2.3 mmol/L and/or treatment for hyperlipidemia).BMC Public Health 2008, 8:189 http://www.biomedcentral.com/1471-2458/8/189
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tional differences, however, there was a reduction in the
absolute gradient of 18% for CRP levels below 3 mg/L and
of 69% for the established risk factors taken together. The
reduction in the latter group was even more pronounced
if also excluding subjects with diabetes from the low-risk
population. Thus, conclusions on the importance of
"modern" and established risk factors depend on which
scale one measures socioeconomic differences in morbid-
ity and mortality. This has important implications for
public health strategies and the preventive potential of
acting on reducing established risk factors rather than
"modern" risk factors. Our results are similar to the results
from a recent population-based study of 2,682 men in
eastern Finland [11]. For highly prevalent risk factors with
strong associations with CVD, as in the case of established
risk factors, there were strong reductions in absolute risk
in each educational category after stratification (i.e., look-
ing at a low-risk population without smoking, hyperten-
sion or hyperlipidemia). There were, however, only rather
small changes in the relative gradient, while for the "mod-
ern" risk factor (here CRP) there were rather small changes
in the relative gradient and only small reductions in abso-
lute risk after stratification (i.e., looking at a population
with CRP-levels below 3 mg/L). It is well known that rel-
ative measures are cumbersome when it comes to making
comparisons, e.g. between age groups, sexes, countries, or
populations [25]. Furthermore, when evaluating the
importance of mediating factors or confounders, relative
comparisons can be misleading as the effect of a given
association depends heavily on the distribution of the
exposure variable in the different categories of the mediat-
ing/confounding factor [11].
Primary and secondary prevention of CVD has mainly
included prevention of established risk factors, and the
risk of disease has decreased by 40% since the mid-1970s
[26]. Regarding social inequalities in cardiovascular
health, however, there have been similar or even widening
relative social inequalities over time [27,28]. Those who
have benefited most from these interventions appear to
have been individuals with a higher level of education,
and the relative inequalities are thus widening [27]. If one
considers the absolute levels, however, there has been a
decrease of CVD in all socioeconomic groups over time.
Thus, the conclusion about the importance of established
risk factors in explaining the socioeconomic differences
depends on the scale on which one measures social ine-
qualities. These are important issues that affect opinions
about where to place the effort in preventive programs –
on established risk factors or on modern risk factors. It has
recently been suggested that even though the use of rela-
tive measures is helpful in the search for mechanistic links
between SEP and CVD, it is important to interpret the
findings against a background of absolute levels of dis-
ease, and on what causes disease [11], in order to better
interpret the effect of a certain factor on a given associa-
tion.
In recent years, there has been increasing recognition of
the inflammatory component of atherogenesis. Levels of
major acute-phase-proteins such as CRP and fibrinogen
have been found to predict acute cardiovascular events in
prospective studies [8]. The inflammatory marker CRP has
been found to be associated with the presence of athero-
sclerosis and to double the risk of future cardiovascular
events when exceeding 3 mg/L [8]. However, there have
also been studies that have shown that the usefulness of
CRP in prediction beyond that of established risk factors
is small [29,30]. Furthermore, previous studies have
shown an inverse association between SEP and levels of
CRP, serum amyloid A (SAA), and fibrinogen [31-37]. In
a recent study on the MDCS cohort, we found that low
SEP was strongly associated with CRP levels, independ-
ently of potential mediating factors e.g., smoking and fac-
tors involved in the metabolic syndrome. Furthermore,
CRP levels were found to be associated with the extent of
carotid atherosclerosis. However, there was only a minor
attenuation of the relative SEP gradient in carotid athero-
sclerosis after adjustment for CRP [9]. Similarly, in the
present study there was only a small reduction in the rela-
Crude incidence rates of first cardiovascular event (i.e.  stroke or coronary event) by educational level in the whole  population (shown as dark grey and light grey bars) and in a  low-risk population (i.e., with no hypertension, no hypercho- lesterolemia and no current smoking) (shown as light grey  bars) Figure 2
Crude incidence rates of first cardiovascular event 
(i.e. stroke or coronary event) by educational level in 
the whole population (shown as dark grey and light 
grey bars) and in a low-risk population (i.e., with no 
hypertension, no hypercholesterolemia and no cur-
rent smoking) (shown as light grey bars). ARD I stands 
for absolute difference in incidence rate between those with 
less than 9 years of education and those with more than 12 
years of education in the whole population. ARD III stands 
for the corresponding difference in the low-risk population.
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tive educational gradient in the risk of cardiovascular
events, and also a small reduction in the absolute educa-
tional gradient after stratification for CRP below 3 mg/L.
It should be noted that this was for the unadjusted meas-
ure of CRP, i.e. some of these reductions in the gradients
were due to established risk factors known to be associ-
ated with CRP such as smoking, hypertension, and BMI
[8]. It is difficult to directly compare the effects of CRP and
established risk factors for several reasons. Firstly, stratifi-
cation of established risk factors also results in a reduction
in mean CRP levels and stratification for CRP results in
lower levels of the established risk factors. The absolute
risk reductions are thus influenced by other risk factors
that correlate with the risk factors for which the analysis
was stratified. Secondly, some of the effects of CRP may be
mediated through the development of other risk factors.
Longitudinal studies have shown that low-grade inflam-
mation is associated with the development of hyperten-
sion, diabetes and large weight gain [38-40]. Similarly, the
effects of the established risk factors could be mediated
through their proinflammatory effects. Thirdly, stratifica-
tion of CRP resulted in a larger group (n = 3,296) than the
group without major risk factors (n = 1,092), and the low-
risk group was therefore a more selected group with lower
cardiovascular risk.
Certain methodological issues must to be addressed.
Firstly, misclassification of endpoint is a possible cause of
bias. However, about 95% of the cases of stroke were con-
firmed by CT and/or autopsy [23]. Vital status of all indi-
viduals at the end of follow-up was updated by data
linkage with the regional stroke register in Malmö, and
with the regional and national myocardial infarction reg-
ister [19,21]. The STROMA is a population-based register
that is known to be better than hospital-based registers
with regard to coverage and potential selection bias [41].
The completeness and validity of the national myocardial
infarction register and STROMA has been documented in
several other studies [22,42]. The proportion of non-hos-
pitalized cases is very small in Sweden. There is no reason
to believe that incomplete retrieval of cases biased the
results.
Misclassification of exposure is a potential cause of bias.
Educational level, usually attained in early adulthood,
should not to be influenced by clinical atherosclerotic dis-
ease, which occurs later in life. The use of education as a
marker of SEP has been shown to be reliable, to have a
low non-response rate and, as it is usually attained in early
adulthood, not to be subject to reverse causation [43,44].
However, education might be a problematic indicator in a
study covering a wide range of age cohorts, i.e. social and
economical values might differ between various birth
cohorts [45]. Other studies have shown a weaker associa-
tion between SEP and various disease outcomes in groups
close to retirement age, which might be partly attributable
to survivor bias [46]. However, an earlier study on the
MDCS showed a similar association between educational
level and risk of future coronary events in subjects below
60 years of age and in the whole population [47].
Furthermore, misclassification of mediating factors is
another potential source of bias. CRP has been suggested
to be a good indicator of low-grade inflammation since
the levels appear to be reasonably stable over time, with
little seasonal variation [48,49]. While some studies have
shown signs of diurnal variation [49], others have not
[50]. CRP has been shown to be related to future cardio-
vascular events [8], and this was also true in our study,
even after adjustment for potential confounders such as
smoking, hypertension, hyperlipidemia, BMI, and diabe-
tes mellitus. The definition of a low-risk population in the
present study was based on the three major cardiovascular
risk factors, i.e., current smoking, hypertension and hyper-
lipidemia. The definition of hypertension using a systolic
blood pressure exceeding 160 mm Hg is in accordance
with the national guidelines at the time of baseline inves-
tigation in the early 1990s.
This study is based on a community-based sample of the
general population, which makes it less sensitive to selec-
tion bias than samples based on workplace or popula-
tions in clinical settings. However, excluding subjects with
known CVD together with the fact that people who partic-
ipate in public health surveys are generally healthier than
the non-participants might lead to an underestimation of
the true associations between the measures of education
and incident cardiovascular events in our study.
Conclusion
As shown in earlier studies, adjustment for cardiovascular
risk factors resulted in a rather small reduction in the rel-
ative educational gradient in incidence of CVD, i.e. 8% for
CRP and 21% for established risk factors taken together.
However, in terms of absolute educational differences in
CVD incidence, the risk reductions were 18% and 69%,
respectively. Thus, the conclusion on the importance of a
risk factor depends on which scale one measures social
inequalities. In the case of highly prevalent risk factors
with strong associations with CVD, as in the case with
established risk factors, there was a strong reduction in
absolute risk in each educational category after stratifica-
tion (i.e. looking at the low-risk population without
smoking, hypertension or hyperlipidemia), resulting in
rather small changes in the relative gradient. With regard
to the "modern" risk factor (here CRP), however, there
were rather small changes in the absolute gradient after
stratification (i.e., looking at subjects with CRP-levels
below 3 mg/L), also resulting in rather small changes in
the relative gradient. Even though, for several reasons, it isBMC Public Health 2008, 8:189 http://www.biomedcentral.com/1471-2458/8/189
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difficult to directly compare the effects of CRP and the
established risk factors, it is essential to be aware of the
fact that the interpretation of the importance of various
risk factors in the association between SEP and CVD dif-
fers depending on which scale is used to measure social
inequalities. These are important issues that affect opin-
ions of where to invest effort in population-wide preven-
tive programs and on the preventive potential of acting on
reducing established risk factors as opposed to "modern"
risk factors. The one-sided use of the relative scale can thus
inhibit efforts to reduce established risk factors in that it
gives priority to research and preventive programs looking
in new directions.
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